| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |